Efficacy and Safety of Direct-acting Antivirals in Hepatitis C Virus-infected Patients Taking Proton Pump Inhibitors

Background and Aims: Direct-acting antiviral (DAA) therapy is the cornerstone of the treatment of chronic hepatitis C virus (HCV) infection. Eradication of HCV, predicted by the attainment of a sustained virologic response (SVR) 12 weeks following DAA therapy, is the goal of this treatment. Interest...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Transl Hepatol
Hoofdauteurs: Wijarnpreecha, Karn, Chesdachai, Supavit, Thongprayoon, Charat, Jaruvongvanich, Veeravich, Ungprasert, Patompong, Cheungpasitporn, Wisit
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: XIA & HE Publishing Inc. 2017
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5719190/
https://ncbi.nlm.nih.gov/pubmed/29226099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2017.00017
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items